Medpace Holdings (MEDP) Free Cash Flow (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Free Cash Flow data on file, last reported at $138.1 million in Q2 2026.

• Quarterly Free Cash Flow fell 3.03% year-over-year to $138.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $706.7 million (up 21.88% YoY) and the FY2025 annual result came in at $681.9 million, up 19.15% from the prior year.
• Free Cash Flow declined to $138.1 million in Q2 2026, from $145.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $235.5 million in Q3 2025 to a low of $37.0 million in Q1 2022.
• A 5-year average of $127.0 million and a median of $132.8 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow decreased 27.18% — and 2024, when it soared 108.58%.
• Tracing MEDP's Free Cash Flow over 5 years: stood at $127.4 million in 2022, then increased by 14.88% to $146.4 million in 2023, then rose by 25.01% to $183.0 million in 2024, then climbed by 2.78% to $188.1 million in 2025, then slipped by 26.59% to $138.1 million in 2026.
• The last three Free Cash Flow figures came in at $138.1 million (Q2 2026), $145.0 million (Q1 2026), and $188.1 million (Q4 2025), per Business Quant data.